Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP2797915

2-benzyl-3-(oxazole/thiazole)-5-(pyrimidin-2-yl)-1(H)-pyrazole derivatives as stimulators of the soluble guanylate cyclase (sGC) for the treatment of e.g. hypertension or heart failure

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    26.12.2012
  • EP published:
    13.7.2016
  • EP application number:
    12812498.9
  • Max expiry date:
    25.12.2032
  • Title:
    2-benzyl-3-(oxazole/thiazole)-5-(pyrimidin-2-yl)-1(H)-pyrazole derivatives as stimulators of the soluble guanylate cyclase (sGC) for the treatment of e.g. hypertension or heart failure

Timeline

Today
26.12.2012EP application
13.7.2016EP Publication

Owner

  • Name:
    Ironwood Pharmaceuticals, Inc.
  • Address:
    301 Binney Street, 2nd Floor, 02142, Cambridge, MA, US

Inventor

  • Name:
    KIM, Charles
  • Address:
    Cambridge, MA, US
  • Name:
    NAKAI, Takashi
  • Address:
    Newton, MA, US
  • Name:
    MOORE, Joel
  • Address:
    Lexington, MA, US
  • Name:
    PERL, Nicholas, Robert
  • Address:
    Apt. 44, Brookline, MA 02446, US
  • Name:
    IM, G-yoon, Jamie
  • Address:
    Cambridge, MA, US
  • Name:
    BARDEN, Timothy, Claude
  • Address:
    Salem, MA, US
  • Name:
    IYENGAR, Rajesh, R.
  • Address:
    West Newton, MA, US
  • Name:
    ZIMMER, Daniel, P.
  • Address:
    Somerville, MA, US
  • Name:
    FRETZEN, Angelika
  • Address:
    Somerville, MA, US
  • Name:
    RENHOWE, Paul, Allan
  • Address:
    Sudbury, MA, US

Priority

  • Number:
    201161580439 P
  • Date:
    27.12.2011
  • Country:
    US
  • Number:
    201261654580 P
  • Date:
    1.6.2012
  • Country:
    US

Classification

  • Categories:
    C07D 413/14, C07D 403/04, C07D 417/14, A61K 31/4155, A61P 43/00

Upload documents